Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD
姜黄素疗法治疗 ADPKD 儿童和年轻人的血管功能障碍
基本信息
- 批准号:9754811
- 负责人:
- 金额:$ 15.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAffectAgeAge-YearsAmericanAntioxidantsAortaArteriesAscorbic AcidAutosomal Dominant Polycystic KidneyBiologicalBlood VesselsCardiovascular DiseasesCardiovascular systemCarotid ArteriesCause of DeathChildChildhoodConduct Clinical TrialsCurcuminCystCystic Kidney DiseasesCystic kidneyDataDevelopmentDiseaseDisease ProgressionDouble-Blind MethodDouble-blind trialEffectivenessEndotheliumEventFunctional disorderFutureGenetic DiseasesGenetic TranscriptionGoalsGrowthHealthHumanHypertensionImpairmentIn VitroInflammationInfusion proceduresKidneyKidney DiseasesLifeMRI ScansMagnetic Resonance ImagingMass Spectrum AnalysisMeasuresMediatingMethodsNatureNutraceuticalOralOxidative StressPatientsPhysiologic pulsePhysiologicalPlacebosPopulationPrognostic MarkerRandomizedRandomized Clinical TrialsRenal functionResearchRodent ModelSpicesTestingTherapeuticTumericUrineVascular Diseasesagedarterial stiffnessbrachial arterycardiovascular disorder preventionendothelial dysfunctionimprovedin vivoinsightkidney cellmortalitynovelpatient subsetspolyphenolpreventpublic health relevancevascular endothelial dysfunctionyoung adult
项目摘要
DESCRIPTION (provided by applicant): Although often considered to be a disease of adults, complications of ADPKD begin in childhood. While the hallmark of ADPKD is the development and continued growth of multiple renal cysts that result in ultimate loss of kidney function, the leading cause of death among affected patients is cardiovascular in nature. Vascular dysfunction (endothelial dysfunction and large elastic artery stiffness) is evident very early in te course of the disease and appears to involve increased oxidative stress and inflammation. Treatment options to prevent CVD in adults with ADPKD are limited, thus childhood may represent a key therapeutic window. Curcumin is a safe, naturally occurring polyphenol found in the Indian spice turmeric that has a unique ability to activate transcription of key antioxidants, suppress inflammation, and reduce proliferation. Aim 1 will assess the efficacy of curcumin (25 mg/kg/day) for improving vascular function in children and young adults (6-22 years of age) with ADPKD, using a 1 year randomized, placebo-controlled, double-blind trial. Aim 2 will determine (in a sub-group of patients 18-22 years of age), if improvements are associated with reduced oxidative stress and inflammation, utilizing state of the art mass spectrometry methods. A third exploratory aim will assess changes in total kidney volume using MRI scans. This study has the potential to establish a novel, safe, and easy to deliver therapy for the treatment of arterial dysfunction, and possibly renal cystic disease, in an understudied population of children and young adults with ADPKD.
描述(由申请人提供):虽然 ADPKD 通常被认为是一种成人疾病,但其并发症始于儿童期。虽然 ADPKD 的特点是多发性肾囊肿的发展和持续生长,最终导致肾功能丧失,但受影响患者的主要死亡原因是心血管疾病。血管功能障碍(内皮功能障碍和大弹性动脉僵硬)在疾病过程的早期就很明显,并且似乎涉及氧化应激和炎症的增加。患有 ADPKD 的成人预防 CVD 的治疗选择有限,因此儿童期可能是一个关键的治疗窗口。姜黄素是一种安全的天然多酚,存在于印度香料姜黄中,具有激活关键抗氧化剂转录、抑制炎症和减少增殖的独特能力。目标 1 将使用一项为期 1 年的随机、安慰剂对照、双盲试验,评估姜黄素(25 毫克/公斤/天)改善 ADPKD 儿童和年轻人(6-22 岁)血管功能的功效。目标 2 将利用最先进的质谱方法确定(在 18-22 岁的患者亚组中)改善是否与氧化应激和炎症减少相关。第三个探索性目标是使用 MRI 扫描评估肾脏总体积的变化。这项研究有可能建立一种新颖、安全且易于实施的疗法,用于治疗未充分研究的 ADPKD 儿童和年轻人群体中的动脉功能障碍,以及可能的肾囊性疾病。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
.
- DOI:10.5414/cn109982
- 发表时间:2020-07
- 期刊:
- 影响因子:1.1
- 作者:Nowak KL;Chonchol M;Jovanovich A;You Z;Ambrosius WT;Cho ME;Glasser S;Lash J;Simmons DL;Taylor A;Weiner D;Rastogi A;Oparil S;Supiano MA
- 通讯作者:Supiano MA
Vascular Dysfunction, Oxidative Stress, and Inflammation in Chronic Kidney Disease.
- DOI:10.34067/kid.0000962019
- 发表时间:2020-06
- 期刊:
- 影响因子:0
- 作者:Nowak KL;Jovanovich A;Farmer-Bailey H;Bispham N;Struemph T;Malaczewski M;Wang W;Chonchol M
- 通讯作者:Chonchol M
Does inflammation affect outcomes in dialysis patients?
- DOI:10.1111/sdi.12686
- 发表时间:2018-07-01
- 期刊:
- 影响因子:1.6
- 作者:Nowak, Kristen L.;Chonchol, Michel
- 通讯作者:Chonchol, Michel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristen Lynn Nowak其他文献
Kristen Lynn Nowak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristen Lynn Nowak', 18)}}的其他基金
Daily Caloric Restriction in Overweight and Obese Adults with ADPKD
患有 ADPKD 的超重和肥胖成人的每日热量限制
- 批准号:
10273578 - 财政年份:2021
- 资助金额:
$ 15.13万 - 项目类别:
Daily Caloric Restriction in Overweight and Obese Adults with ADPKD
患有 ADPKD 的超重和肥胖成人的每日热量限制
- 批准号:
10436361 - 财政年份:2021
- 资助金额:
$ 15.13万 - 项目类别:
Daily Caloric Restriction in Overweight and Obese Adults with ADPKD
患有 ADPKD 的超重和肥胖成人的每日热量限制
- 批准号:
10676347 - 财政年份:2021
- 资助金额:
$ 15.13万 - 项目类别:
Daily Caloric Restriction in Overweight and Obese Adults with ADPKD
患有 ADPKD 的超重和肥胖成人的每日热量限制
- 批准号:
10623248 - 财政年份:2021
- 资助金额:
$ 15.13万 - 项目类别:
Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD
姜黄素疗法治疗 ADPKD 儿童和年轻人的血管功能障碍
- 批准号:
9535985 - 财政年份:2015
- 资助金额:
$ 15.13万 - 项目类别:
Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD
姜黄素疗法治疗 ADPKD 儿童和年轻人的血管功能障碍
- 批准号:
9117510 - 财政年份:2015
- 资助金额:
$ 15.13万 - 项目类别:
Vascular Endothelial Dysfunction in Older Adults: Dietary Sodium Restriction
老年人血管内皮功能障碍:饮食钠限制
- 批准号:
7752986 - 财政年份:2009
- 资助金额:
$ 15.13万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 15.13万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 15.13万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 15.13万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 15.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 15.13万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 15.13万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 15.13万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 15.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 15.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 15.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)